FDA Inspection 1002004 — Yale New Haven Health, Lawrence & Memorial Hospital

Yale New Haven Health, Lawrence & Memorial Hospital — FEI 1272759

The FDA completed an inspection of Yale New Haven Health, Lawrence & Memorial Hospital on February 24, 2017 in New London, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 24, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New London, CT (United States)